WELLSTAR announces it has closed on a $62 million equity placement supported by Mawer Investment Management, Edgepoint Wealth Management, PICTON Investments and the management team of WELL and WELLSTAR to… Read More
Franklin Lakes, NJ – BD (Becton, Dickinson and Company), a leading global medical technology company, is showcasing the latest advances in connected medication management technology this week at the American… Read More
Follow-up data from CARTITUDE-4 show at least 80 percent of as-treated standard-risk patients remained progression and treatment-free following a single infusion as early as second line Data suggest stronger immune… Read More
With continued funding from a Terry Fox New Frontiers Program Project Grant (PPG), researchers at the University of British Columbia (UBC) have answered one of the biggest questions in the… Read More
New data from Cohort 4 of the SunRISe-1 study show more than 95 percent of patients remained progression free at one year, with more than 92 percent not undergoing bladder… Read More
